White label ELPA - ClinicalTrials.eu

Study on Dose Flexibility of Upadacitinib for Adults with Moderate to Severe Atopic Dermatitis

Not recruiting

3 1 1
Investigated diseases:
- Dermatitis atopic
Investigated drugs:
- Upadacitinib
+4
Long-Term Safety Study of Azacitidine for Patients with Blood Disorders Who Previously Participated in Azacitidine Clinical Trials

Not recruiting

2 1 1
Investigated diseases:
- Bone marrow failure
Investigated drugs:
- Azacitidine
Study of Zanubrutinib and Tacrolimus for Patients with Primary Membranous Nephropathy

Not recruiting

4 1 1 1
Investigated diseases:
- Glomerulonephritis membranous
Investigated drugs:
- Tacrolimus
- Zanubrutinib
Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Not recruiting

3 1 1
Investigated diseases:
- Thrombosis prophylaxis
- Atrial fibrillation
Investigated drugs:
- Asundexian
- Apixaban
+16
Study Comparing Atogepant and Topiramate for Preventive Treatment in Adults with Migraine

Not recruiting

3 1 1
Investigated diseases:
Investigated drugs:
- Atogepant
- Topiramate
+3
Study on the Effectiveness of Mesenchymal Stromal Cells in Children with Steroid-Refractory Acute Graft-Versus-Host Disease

Not recruiting

2 1 1 1
Investigated diseases:
- Acute graft versus host disease
Investigated drugs:
Study on Human Normal Immunoglobulin to Prevent Early Infections in Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

Not recruiting

2 1 1 1
Investigated diseases:
- Plasma cell myeloma
Investigated drugs:
- Human Normal Immunoglobulin
Study on the Safety and Effectiveness of Furmonertinib vs. Platinum-Based Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer

Not recruiting

3 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
Study on the Effectiveness and Safety of Ruxolitinib Cream for Adults with Chronic Hand Eczema

Not recruiting

2 1
Investigated diseases:
- Hand dermatitis
Investigated drugs:
- Ruxolitinib
Study on the Safety and Effects of MBF-015 for Patients with Huntington’s Disease

Not recruiting

2 1 1
Investigated diseases:
- Huntington’s disease
Investigated drugs:
- Mbf-015

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies